Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
Hammarsten J, Högstedt B. Hammarsten J, et al. Eur Urol. 2001 Feb;39(2):151-8. doi: 10.1159/000052430. Eur Urol. 2001. PMID: 11223674
One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms.
Stranne J, Damber JE, Fall M, Hammarsten J, Knutson T, Peeker R. Stranne J, et al. Among authors: hammarsten j. Scand J Urol Nephrol. 2009;43(3):199-205. doi: 10.1080/00365590902833747. Scand J Urol Nephrol. 2009. PMID: 19347773
Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
Haghsheno MA, Mellström D, Behre CJ, Damber JE, Johansson H, Karlsson M, Lorentzon M, Peeker R, Barret-Connor E, Waern E, Sundh V, Ohlsson C, Hammarsten J. Haghsheno MA, et al. Among authors: hammarsten j. J Urol. 2013 Aug;190(2):608-14. doi: 10.1016/j.juro.2013.01.104. Epub 2013 Feb 8. J Urol. 2013. PMID: 23399651
Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
Haghsheno MA, Mellström D, Peeker R, Hammarsten J, Lorentzon M, Sundh V, Karlsson M, Ohlsson C, Damber JE. Haghsheno MA, et al. Among authors: hammarsten j. Scand J Urol. 2015 Apr;49(2):155-61. doi: 10.3109/21681805.2014.936495. Epub 2014 Sep 25. Scand J Urol. 2015. PMID: 25253423
Urological aspects of the metabolic syndrome.
Hammarsten J, Peeker R. Hammarsten J, et al. Nat Rev Urol. 2011 Aug 2;8(9):483-94. doi: 10.1038/nrurol.2011.112. Nat Rev Urol. 2011. PMID: 21811224 Review.
Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J, Högstedt B. Hammarsten J, et al. Eur J Cancer. 2005 Dec;41(18):2887-95. doi: 10.1016/j.ejca.2005.09.003. Epub 2005 Oct 20. Eur J Cancer. 2005. PMID: 16243513
Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J, Högstedt B. Hammarsten J, et al. Scand J Urol Nephrol. 2002;36(5):330-8. doi: 10.1080/003655902320783827. Scand J Urol Nephrol. 2002. PMID: 12487736
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J, Högstedt B. Hammarsten J, et al. Blood Press. 2004;13(1):47-55. doi: 10.1080/08037050310025735. Blood Press. 2004. PMID: 15083641
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia.
Hammarsten J, Damber JE, Karlsson M, Knutson T, Ljunggren O, Ohlsson C, Peeker R, Smith U, Mellström D. Hammarsten J, et al. Prostate Cancer Prostatic Dis. 2009;12(2):160-5. doi: 10.1038/pcan.2008.50. Epub 2008 Sep 30. Prostate Cancer Prostatic Dis. 2009. PMID: 18825163
A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer.
Hammarsten J, Damber JE, Peeker R, Mellström D, Högstedt B. Hammarsten J, et al. Cancer Epidemiol. 2010 Oct;34(5):574-9. doi: 10.1016/j.canep.2010.06.014. Epub 2010 Aug 10. Cancer Epidemiol. 2010. PMID: 20702155
115 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback